Rating Rationale
November 11, 2022 | Mumbai
Indofil Industries Limited
Ratings reaffirmed at 'CRISIL A+ / Positive / CRISIL A1+'; CP withdrawn
 
Rating Action
Total Bank Loan Facilities RatedRs.2128 Crore
Long Term RatingCRISIL A+/Positive (Reaffirmed)
Short Term RatingCRISIL A1+ (Reaffirmed)
 
Rs.200 Crore Commercial PaperCRISIL A1+ (Withdrawn)
Note: None of the Directors on CRISIL Ratings Limited’s Board are members of rating committee and thus do not participate in discussion or assignment of any ratings. The Board of Directors also does not discuss any ratings at its meetings.
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has reaffirmed its ratings on the bank facilities of Indofil Industries Limited (IIL; part of Indofil group) at CRISIL A+/Positive/CRISIL A1+. The rating on the commercial paper programme has been reaffirmed at ‘CRISIL A1+’ and subsequently withdrawn as there was no outstanding against the facility. The same is in line with CRISIL Ratings’ withdrawal policy.

 

The rating continues to reflect an established market position in the fungicides segment, geographically diversified revenue, an established distribution network, and a strong relationship with reputed customers. Furthermore, the financial risk profile is strong marked by healthy networth, comfortable capital structure, and strong debt protection metrics. These strengths are partially offset by working capital-intensive operations, susceptibility in demand to fluctuations in rainfall and regulatory risks associated with product approvals in key geographies.

Analytical Approach

For arriving at its ratings, CRISIL Ratings has fully consolidated the business and financial risk profiles of IIL, its 11 subsidiaries and partly consolidated the 2 joint ventures, together referred to as 'Indofil group', which are strategically important to, and have a significant degree of operational integration with IIL. CRISIL Ratings considers these entities as being strategic to IIL in view of their strong integration with IIL’s operations.

 

Please refer Annexure - List of a Consolidated, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description

Strengths:

Established market position in the fungicides market with geographically diversified revenue

The group has been in the agrochemicals industry since 1962. Over the years, it has diversified in terms of geography as well as products with steady growth in revenues at a 7% CAGR for the past four years ending fiscal 2022. The share of exports in the revenue has remained stable at around 40% to 45% for past 3 fiscals ended fiscal 2022. The group has presence in more than 100 countries in Asia, Europe, South America etc. Revenues grew to Rs 2796 crores in fiscal 2022 as compared to Rs 2420 crores in fiscal 2021, supported by healthy demand from domestic market as well as international regions including South America and Latin America. CRISIL Ratings believes that the business risk profile continues to be aided by such geographical diversity.

 

Established distribution network and strong relationship with reputed customers

With around 892 registrations (a major entry barrier due to long gestation period) and export reach in more than 100 countries, the group has been well-positioned to gain from increased consumption of pesticides globally. The group has well established distribution network of 4645 distributors and 48000 retailers in the domestic market. Further a network of 550 global distributors gives it a global competitive advantage. Over the past few years, group has focused on expanding its global presence and this has been a major revenue driver for the group.

 

Strong financial risk profile

The group's strong financial risk profile is marked by strong networth of Rs 2213 crore and comfortable gearing and TOLANW ratios of 0.31 times and 0.73 times, respectively, as on March 31, 2022. Management is committed to maintain gearing below 0.6 at all times in the absence of large debt funded capital expenditure (capex) or acquisition as well as supported by group’s debt prepayments. Reduction in debt levels has led to healthy debt protection metrics with interest coverage and net cash accrual to adjusted debt ratios of above 9 times and 0.43 time, respectively, in fiscal 2022 (improved from 7.5 times and 0.22 times, respectively, in fiscal 2021). The financial risk profile is expected to remain strong over the medium term with controlled reliance on external debt.

 

Weakness:

Working capital-intensive operations

The group's operations are working capital intensive because of nature of industry. Gross current assets were high at 215-285 days over the four fiscals ended March 31, 2022, driven by sizeable debtors and inventory. While Inventory levels have remained around 97 days, debtor days has gradually improved to 103 days (from 109 days a year before) as on March 31, 2022, supported by stricter control on debtors. CRISIL Ratings expects improvement in the working capital cycle to sustain over the medium term; however, group’s operations will continue to remain working capital intensive over the medium term.

 

Susceptibility to fluctuations in rainfall and regulatory risks associated with product approvals in key geographies

The demand for agrochemicals is driven by agricultural production, which in turn depends on the extent of rainfall. As a result, group's revenue and profitability as dependent on extent of rainfall. Hence, operating profitability has remained volatile between 12-19% over the past 4 fiscals ended fiscal 2022.

The agrochemicals industry, particularly export, is sensitive to changes in government policies associated with product approval process Changes in regulations could increase the variety of tests and data required, and make it more difficult for exporters to obtain registrations. Considering the nature of toxicity on human health, product usage and its environmental impacts, group has to have strict compliance of local laws and regulations. Any claim on infringement of intellectual property laws or change in import/export policy may also have detrimental impact on the revenue and profitability.

Liquidity: Strong

Cash accruals are expected to remain healthy between Rs 280-300 crore in fiscal 2023 and fiscal 2024 and are expected to be sufficient against repayment obligation of Rs 91 crore and Rs 72 crore, respectively. Bank limit was utilized on average at 46% in the last 12 months ending September 2022. Liquidity is further augmented by cash and cash equivalent (cash, free fixed deposit and liquid mutual fund) of Rs 636 crore as on March 2022 in IIL. With no major capital expenditure plan, liquidity should remain comfortable over the medium term. With gearing of 0.31 times as on March 31, 2022, group has sufficient gearing headroom, to raise additional debt to meet its capex/working capital requirement. CRISIL Ratings expects internal accrual and cash and cash equivalents to be sufficient to meet its repayment obligations as well as working capital requirements, over the medium term.

Outlook Positive

CRISIL Ratings believes the group will continue to benefit over the medium term from an established presence in the agrochemicals industry, geographically diversified revenue, and healthy operating efficiency.

Rating Sensitivity factors

Upward Factor

  • Sustenance of revenue growth in and operating profitability at above 14% leading to higher cash accruals
  • Sustenance in working capital cycle (with GCAs net-off cash below 200 days) and hence capital structure

 

Downward Factor

  • Stretch in working capital cycle or large unexpected cash payout constraining financial flexibility
  • Large debt-funded capex or substantial acquisition, leading to gearing above 1 time and
  • Any adverse developments on the pending arbitration at promoter level and regulations regarding  Mancozeb in India

About the Group

IIL, established in 1962, is part of the KK Modi group. The company manufactures agrochemicals (technical and formulations) and specialty and performance chemicals, which accounted for 89% and 11%, respectively, of revenue in fiscal 2021. It plants are located Dahej, Gujarat. The corporate office is in Mumbai.

 

IIL has various subsidiaries in The Netherlands, Bangladesh, Costa Rica, Brazil, Philippines, Indonesia and Italy which cater to marketing and distribution of IIL's products across the globe.  IIL also has formed two JV (Joint Venture) namely Indo Baijin Chemicals Private Limited (IBCL) and Indo Reagens Polymer Additives Private Limited (IPPL).

 

IBCL is a 51:49 joint venture (JV) with Shanghai Baijin Chemicals Group Co Ltd. The JV was formed to set up a manufacturing plant for producing 66,000 MT per annum of carbon disulphide (CS2) using natural gas as raw material in Dahej. CS2 is one of the major raw materials for mancozeb and constitutes around 25% of the raw material requirement. The unit commenced operations in April 2014.

 

Key Financial Indicators- Consolidated

As on / for the period ended March 31

 

2022

2021

Operating income

Rs crore

2,795.99

2,420.22

Reported profit after tax

Rs crore

210.75

77.85

PAT margins

%

7.83

2.77

Adjusted Debt/Adjusted Net worth

Times

0.34

0.45

Interest coverage

Times

8.36

7.03

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings` complexity levels are assigned to various types of financial instruments and are included (where applicable) in the ‘Annexure – Details of Instrument’ in this Rating Rationale.

CRISIL Ratings will disclose complexity level for all securities – including those that are yet to be placed - based on available information. The complexity level for instruments may be updated, where required, in the rating rationale published subsequent to the issuance of the instrument when details on such features are available.

For more details on the CRISIL Ratings` complexity levels please visit www.crisil.com/complexity-levels. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of Instrument

Date of Allotment

Coupon Rate (%)

Maturity Date

Issue Size (Rs.Crore)

Complexity levels

Rating Assigned with Outlook

NA

Cash Credit & Working Capital demand loan

NA

NA

NA

914.5

NA

CRISIL A+/Positive

NA

Foreign Currency Term Loan

NA

NA

Mar-2026

252.3

NA

CRISIL A+/Positive

NA

Long Term Loan

NA

NA

Mar-2025

15.5

NA

CRISIL A+/Positive

NA

Long term Unsecured Loan

NA

NA

NA

125.9

NA

CRISIL A+/Positive

NA

Non-Fund Based Limit

NA

NA

NA

504.5

NA

CRISIL A1+

NA

Proposed Fund Based Bank Limits

NA

NA

NA

294.8

NA

CRISIL A+/Positive

NA

Proposed Non Fund Based Limits

NA

NA

NA

20.5

NA

CRISIL A1+

NA

Commercial Paper

NA

NA

7-365 days

200

Simple

Withdrawn

 

Annexure – List of entities consolidated

Names of Entities Consolidated

Extent of Consolidation

Rationale for Consolidation

Indofil Industries (Netherlands) B.V.

Full

Wholly owned subsidiary

Indofil Bangladesh Industries Pvt. Ltd.

Full

Wholly owned subsidiary

Indofil Costa Rica S.A.

Full

Wholly owned subsidiary

Indofil Industries DO Brasil Ltda.

Full

Wholly owned subsidiary

Indofil Phillipines Inc

Full

Wholly owned subsidiary

PT Indofil Industries Indonesia

Full

Wholly owned subsidiary

Finkotech Private Limited

Full

Wholly owned subsidiary

Agrowin Biosciences S.r.I

Full

80% subsidiary

Indofil Industries (International) B.V.

Full

Wholly owned subsidiary

Good Investment (India) Ltd.

Full

Wholly owned subsidiary

Quick Investment (India) Ltd.

Full

Wholly owned subsidiary

Indobaijin Chemicals Private Limited

51%

Joint Venture, strong operational and financial linkages

Indo Reagens Polymer Additives Pvt. Ltd.

49.9%

Joint Venture, strong operational and financial linkages till August 2021

Annexure - Rating History for last 3 Years
  Current 2022 (History) 2021  2020  2019  Start of 2019
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT 1603.0 CRISIL A+/Positive   -- 12-11-21 CRISIL A+/Positive 20-10-20 CRISIL A+/Stable 22-08-19 CRISIL A+/Stable CRISIL A+/Stable
      --   --   -- 02-06-20 CRISIL A+/Stable 05-07-19 CRISIL A+/Stable --
Non-Fund Based Facilities ST 525.0 CRISIL A1+   -- 12-11-21 CRISIL A1+ 20-10-20 CRISIL A1+ 22-08-19 CRISIL A1+ CRISIL A1+
      --   --   -- 02-06-20 CRISIL A1+ 05-07-19 CRISIL A1+ --
Commercial Paper ST 200.0 Withdrawn   -- 12-11-21 CRISIL A1+ 20-10-20 CRISIL A1+ 22-08-19 CRISIL A1+ CRISIL A1+
      --   --   -- 02-06-20 CRISIL A1+ 05-07-19 CRISIL A1+ --
Non Convertible Debentures LT   --   --   -- 20-10-20 Withdrawn 22-08-19 CRISIL A+/Stable CRISIL A+/Stable
      --   --   -- 02-06-20 CRISIL A+/Stable 05-07-19 CRISIL A+/Stable --
All amounts are in Rs.Cr.
Annexure - Details of Bank Lenders & Facilities
Facility Amount (Rs.Crore) Name of Lender Rating
Cash Credit & Working Capital Demand Loan 245 Union Bank of India CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 50 The Cosmos Co-Operative Bank Limited CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 37 HDFC Bank Limited CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 115 DBS Bank India Limited CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 105 Cooperatieve Rabobank U.A. CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 60 IndusInd Bank Limited CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 10 The South Indian Bank Limited CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 52.5 RBL Bank Limited CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 90 The Hongkong and Shanghai Banking Corporation Limited CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 75 Canara Bank CRISIL A+/Positive
Cash Credit & Working Capital Demand Loan 75 IDFC FIRST Bank Limited CRISIL A+/Positive
Foreign Currency Term Loan 86.2 IndusInd Bank Limited CRISIL A+/Positive
Foreign Currency Term Loan 80.5 Canara Bank CRISIL A+/Positive
Foreign Currency Term Loan 80.5 Union Bank of India CRISIL A+/Positive
Foreign Currency Term Loan 5.1 Exim Bank CRISIL A+/Positive
Long Term Loan 15.5 DBS Bank India Limited CRISIL A+/Positive
Long Term Unsecured Loan 100 IDFC FIRST Bank Limited CRISIL A+/Positive
Long Term Unsecured Loan 25.9 DCB Bank Limited CRISIL A+/Positive
Non-Fund Based Limit 17.5 RBL Bank Limited CRISIL A1+
Non-Fund Based Limit 115 Union Bank of India CRISIL A1+
Non-Fund Based Limit 63 HDFC Bank Limited CRISIL A1+
Non-Fund Based Limit 115 The Hongkong and Shanghai Banking Corporation Limited CRISIL A1+
Non-Fund Based Limit 60 The Cosmos Co-Operative Bank Limited CRISIL A1+
Non-Fund Based Limit 18 IndusInd Bank Limited CRISIL A1+
Non-Fund Based Limit 88 Cooperatieve Rabobank U.A. CRISIL A1+
Non-Fund Based Limit 28 Canara Bank CRISIL A1+
Proposed Fund-Based Bank Limits 294.8 Not Applicable CRISIL A+/Positive
Proposed Non Fund based limits 20.5 Not Applicable CRISIL A1+

This Annexure has been updated on 11-Nov-2022 in line with the lender-wise facility details as on 07-Dec-2021 received from the rated entity.

Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating Criteria for Fertiliser Industry
CRISILs Criteria for rating short term debt
CRISILs Criteria for Consolidation

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Rahul Subrato Kumar Guha
Director
CRISIL Ratings Limited
D:+91 22 4097 8320
rahul.guha@crisil.com


Ankita Gupta
Associate Director
CRISIL Ratings Limited
D:+91 22 4097 8104
ankita.gupta@crisil.com


Shalaka Singh
Manager
CRISIL Ratings Limited
B:+91 22 3342 3000
Shalaka.Singh@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations.

CRISIL is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.


For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL’s privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale (‘report’) that is provided by CRISIL Ratings Limited (‘CRISIL Ratings’). To avoid doubt, the term ‘report’ includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, ‘CRISIL Ratings Parties’) guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to:
https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.

 

 

CRISIL Ratings uses the prefix ‘PP-MLD’ for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html